Iris Scala

Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome.

G. Andria, I. Scala, V. Iacobazzi, 2011, Molecular genetics and metabolism.

Expanding the clinical and neuroradiologic phenotype of primary microcephaly due to ASPM mutations

I Scala, Alain Verloes, M. Elmaleh, 2009, Neurology.

Serious Games in the new era of digital-health interventions: A narrative review of their therapeutic applications to manage neurobehavior in neurodevelopmental disorders

A. Turchetta, M. Murero, F. Marzano, 2023, Neuroscience & Biobehavioral Reviews.

The contribution of the citrate pathway to oxidative stress in Down syndrome

P. Convertini, A. Menga, G. Andria, 2016, Immunology.

Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience

B. Capaldo, G. Andria, I. Scala, 2015, Orphanet Journal of Rare Diseases.

Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring

P. Mastroiacovo, G. Andria, I. Scala, 2006, Genetics in Medicine.

Genetic Risk Factors for Neural Tube Defects: Folic Acid Supplementation and Prevention of Birth Defects

G. Andria, I. Scala, Iris Scala, 2006 .

Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome.

Domenico de Rasmo, A. Signorile, S. Papa, 2013, Biochimica et biophysica acta.